These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23488777)

  • 21. Preparation and Characterization of Simvastatin Nanocapsules: Encapsulation of Hydrophobic Drugs in Calcium Alginate.
    Ahmadi M; Madrakian T; Ghavami S
    Methods Mol Biol; 2020; 2125():47-56. PubMed ID: 30159829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium phosphate biomaterials as bone drug delivery systems: a review.
    Verron E; Khairoun I; Guicheux J; Bouler JM
    Drug Discov Today; 2010 Jul; 15(13-14):547-52. PubMed ID: 20546919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of biphasic calcium phosphates on drug release and biological and mechanical properties of poly(epsilon-caprolactone) composite membranes.
    Kim HW; Knowles JC; Kim HE
    J Biomed Mater Res A; 2004 Sep; 70(3):467-79. PubMed ID: 15293321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment.
    Safwat S; Hathout RM; Ishak RA; Mortada ND
    J Liposome Res; 2017 Mar; 27(1):1-10. PubMed ID: 26872624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catechin-rich oil palm leaf extract enhances bone calcium content of estrogen-deficient rats.
    Bakhsh A; Mustapha NM; Mohamed S
    Nutrition; 2013 Apr; 29(4):667-72. PubMed ID: 23290096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone-supportive behavior of microplasma-sprayed CaP-coated implants: mechanical and histological outcome in the goat.
    Junker R; Manders PJ; Wolke J; Borisov Y; Jansen JA
    Clin Oral Implants Res; 2010 Feb; 21(2):189-200. PubMed ID: 19958376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
    Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
    J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite.
    Verron E; Gauthier O; Janvier P; Pilet P; Lesoeur J; Bujoli B; Guicheux J; Bouler JM
    Biomaterials; 2010 Oct; 31(30):7776-84. PubMed ID: 20643480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simvastatin ointment, a new treatment for skin inflammatory conditions.
    Adami M; Prudente Ada S; Mendes DA; Horinouchi CD; Cabrini DA; Otuki MF
    J Dermatol Sci; 2012 May; 66(2):127-35. PubMed ID: 22455735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of free-standing hybrid colloidal membranes via assembly of liponanocapsules.
    Fukui Y; Kameyama S; Fujimoto K
    J Biomater Sci Polym Ed; 2017; 28(10-12):1010-1024. PubMed ID: 28276999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release of simvastatin from biodegradable hydrogels promotes odontoblastic differentiation.
    Miyazawa A; Matsuno T; Asano K; Tabata Y; Satoh T
    Dent Mater J; 2015; 34(4):466-74. PubMed ID: 26235711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanocapsules engineered from polyhedral ZIF-8 templates for bone-targeted hydrophobic drug delivery.
    Wang X; Miao D; Liang X; Liang J; Zhang C; Yang J; Kong D; Wang C; Sun H
    Biomater Sci; 2017 Mar; 5(4):658-662. PubMed ID: 28246671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment?
    Laster AJ; Tanner SB
    Rheum Dis Clin North Am; 2011 Aug; 37(3):323-36, v. PubMed ID: 22023894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomechanical comparison of different surface modifications for dental implants.
    Ferguson SJ; Langhoff JD; Voelter K; von Rechenberg B; Scharnweber D; Bierbaum S; Schnabelrauch M; Kautz AR; Frauchiger VM; Mueller TL; van Lenthe GH; Schlottig F
    Int J Oral Maxillofac Implants; 2008; 23(6):1037-46. PubMed ID: 19216272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release of simvastatin from biomimetic β-TCP drug delivery system.
    Chou J; Ito T; Bishop D; Otsuka M; Ben-Nissan B; Milthorpe B
    PLoS One; 2013; 8(1):e54676. PubMed ID: 23349949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.
    Nam SH; Jeong JH; Che X; Lim KE; Nam H; Park JS; Choi JY
    Bone; 2012 Jan; 50(1):149-55. PubMed ID: 22036912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
    Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
    Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration.
    Tanigo T; Takaoka R; Tabata Y
    J Control Release; 2010 Apr; 143(2):201-6. PubMed ID: 20060429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of pharmacotherapy of osteoporosis in cardiology patients.
    Zapolski T; Wysokiński A
    Cardiol J; 2010; 17(4):335-43. PubMed ID: 20690088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.